- Albumin, the most abundant protein in blood plasma, is a crucial component in various medical and pharmaceutical applications, including maintaining osmotic pressure, transporting substances, and acting as a vital ingredient in drug formulations, vaccines, and cell culture media. Its versatility and critical physiological roles make it an indispensable part of modern healthcare
- The escalating demand for albumin is primarily fueled by the increasing prevalence of chronic diseases such as liver cirrhosis, kidney diseases, and burns, which often necessitate albumin supplementation. In addition, the growing adoption of albumin in non-therapeutic applications such as cosmetics and wound care, coupled with continuous advancements in biotechnology for albumin production and rising investments in healthcare infrastructure, are driving market expansion
- North America dominates the albumin market with the largest revenue share of 37.09% in 2024, characterized by its advanced healthcare infrastructure, a thriving pharmaceutical industry, a high prevalence of chronic diseases, and substantial research and development capabilities
- Asia-Pacific is expected to be the fastest growing region in the albumin market during the forecast period due to increasing urbanization, rising disposable incomes, improving healthcare infrastructure, and a growing focus on medical research and preventative treatment in countries
- Bovine serum albumin segment dominates the albumin market with a market share of 41.57% in 2024, driven by its cost-effectiveness, high purity, stability, and widespread use as a standard protein in various research, diagnostic, and biopharmaceutical applications
